| Year |
Citation |
Score |
| 2019 |
Lubkin A, Lee WL, Alonzo F, Wang C, Aligo J, Keller M, Girgis NM, Reyes-Robles T, Chan R, O'Malley A, Buckley P, Vozhilla N, Vasquez MT, Su J, Sugiyama M, et al. Staphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice. Cell Host & Microbe. PMID 30799265 DOI: 10.1016/J.Chom.2019.01.015 |
0.326 |
|
| 2014 |
Nacer A, Movila A, Sohet F, Girgis NM, Gundra UM, Loke P, Daneman R, Frevert U. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. Plos Pathogens. 10: e1004528. PMID 25474413 DOI: 10.1371/Journal.Ppat.1004528 |
0.381 |
|
| 2014 |
Girgis NM, Gundra UM, Ward LN, Cabrera M, Frevert U, Loke P. Ly6Chigh monocytes become alternatively activated macrophages in schistosome granulomas with help from CD4+ cells. Plos Pathogens. 10: e1004080. PMID 24967715 DOI: 10.1371/Journal.Ppat.1004080 |
0.395 |
|
| 2014 |
Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD, Wiens KE, Tang MS, Basu-Roy U, Mansukhani A, Allen JE, Loke P. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood. 123: e110-22. PMID 24695852 DOI: 10.1182/Blood-2013-08-520619 |
0.358 |
|
| 2013 |
Girgis NM, Gundra UM, Loke P. Immune regulation during helminth infections. Plos Pathogens. 9: e1003250. PMID 23637593 DOI: 10.1371/Journal.Ppat.1003250 |
0.357 |
|
| 2013 |
Gregg B, Taylor BC, John B, Tait-Wojno ED, Girgis NM, Miller N, Wagage S, Roos DS, Hunter CA. Replication and distribution of Toxoplasma gondii in the small intestine after oral infection with tissue cysts. Infection and Immunity. 81: 1635-43. PMID 23460516 DOI: 10.1128/Iai.01126-12 |
0.38 |
|
| 2012 |
Broadhurst MJ, Leung JM, Lim KC, Girgis NM, Gundra UM, Fallon PG, Premenko-Lanier M, McKerrow JH, McCune JM, Loke P. Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent type-2 immunity to helminth infection in mice. Plos Pathogens. 8: e1002883. PMID 22927819 DOI: 10.1371/Journal.Ppat.1002883 |
0.445 |
|
| 2012 |
Hudson PN, Self J, Weiss S, Braden Z, Xiao Y, Girgis NM, Emerson G, Hughes C, Sammons SA, Isaacs SN, Damon IK, Olson VA. Elucidating the role of the complement control protein in monkeypox pathogenicity. Plos One. 7: e35086. PMID 22496894 DOI: 10.1371/Journal.Pone.0035086 |
0.671 |
|
| 2011 |
Girgis NM, Dehaven BC, Xiao Y, Alexander E, Viner KM, Isaacs SN. The Vaccinia virus complement control protein modulates adaptive immune responses during infection. Journal of Virology. 85: 2547-56. PMID 21191012 DOI: 10.1128/Jvi.01474-10 |
0.636 |
|
| 2010 |
DeHaven BC, Girgis NM, Xiao Y, Hudson PN, Olson VA, Damon IK, Isaacs SN. Poxvirus complement control proteins are expressed on the cell surface through an intermolecular disulfide bridge with the viral A56 protein. Journal of Virology. 84: 11245-54. PMID 20719953 DOI: 10.1128/Jvi.00372-10 |
0.649 |
|
| 2008 |
Girgis NM, Dehaven BC, Fan X, Viner KM, Shamim M, Isaacs SN. Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack. Journal of Virology. 82: 4205-14. PMID 18287241 DOI: 10.1128/Jvi.02426-07 |
0.663 |
|
| 2007 |
Viner KM, Girgis N, Kwak H, Isaacs SN. B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals. Virology. 361: 356-63. PMID 17188733 DOI: 10.1016/J.Virol.2006.11.020 |
0.676 |
|
| Show low-probability matches. |